{"id":"slow-titration","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL5789845","moleculeType":null,"molecularWeight":"496.99"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved by slowly increasing the dose over time, allowing the body to adjust to the medication. This approach can help to reduce the risk of adverse events and improve patient compliance.","oneSentence":"Slow Titration is a medication that helps to gradually increase the dose of a drug to minimize side effects.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:20.349Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT03109288","phase":"PHASE1, PHASE2","title":"Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-08-11","conditions":"Multiple Sclerosis","enrollment":250},{"nctId":"NCT06906640","phase":"NA","title":"Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-10-28","conditions":"Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM)","enrollment":420},{"nctId":"NCT05746273","phase":"PHASE2","title":"Depressed Mood Improvement Through Nicotine Dosing 3","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-04-15","conditions":"Depressive Disorder","enrollment":60},{"nctId":"NCT04469959","phase":"PHASE2","title":"Dopaminergic Dysfunction in Late-Life Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-02-15","conditions":"Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant","enrollment":100},{"nctId":"NCT07382921","phase":"NA","title":"Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01-30","conditions":"Fibromyalgia, Pregabalin, Pain","enrollment":164},{"nctId":"NCT06643728","phase":"PHASE2","title":"A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-10-21","conditions":"Obesity, Overweight","enrollment":240},{"nctId":"NCT07030868","phase":"PHASE2","title":"A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2025-06-19","conditions":"Obesity, Overweight, Type 2 Diabetes","enrollment":1},{"nctId":"NCT07011797","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corxel Pharmaceuticals","startDate":"2025-06-17","conditions":"Obesity","enrollment":250},{"nctId":"NCT06569355","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population","status":"COMPLETED","sponsor":"Vincentage Pharma Co., Ltd","startDate":"2023-12-27","conditions":"Obesity, Overweight","enrollment":250},{"nctId":"NCT06971250","phase":"EARLY_PHASE1","title":"Peripheral KV7 Activation for Pain Relief","status":"COMPLETED","sponsor":"Stefan Heber","startDate":"2025-05-08","conditions":"Pain","enrollment":32},{"nctId":"NCT06924255","phase":"PHASE4","title":"An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia","status":"NOT_YET_RECRUITING","sponsor":"Collaborative Neuroscience Research, LLC","startDate":"2025-04","conditions":"Schizophrenia Disorders","enrollment":100},{"nctId":"NCT05462340","phase":"PHASE1","title":"PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2022-08-18","conditions":"Schizophrenia","enrollment":117},{"nctId":"NCT06572449","phase":"PHASE3","title":"Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia","status":"COMPLETED","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2024-10-28","conditions":"Schizophrenia","enrollment":173},{"nctId":"NCT06066710","phase":"EARLY_PHASE1","title":"Propranolol in Primary Progressive Aphasia","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2025-01-13","conditions":"Aphasia, Primary Progressive","enrollment":30},{"nctId":"NCT04741945","phase":"PHASE2","title":"Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS","status":"RECRUITING","sponsor":"Kirsten Grønbæk","startDate":"2021-12-13","conditions":"Preleukemia, Myelodysplastic Neoplasm, Cytopenia","enrollment":40},{"nctId":"NCT04433767","phase":"PHASE2","title":"Depressed Mood Improvement Through Nicotine Dosing 2","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-12-15","conditions":"Depressive Disorder","enrollment":29},{"nctId":"NCT02357849","phase":"PHASE4","title":"Fluoxetine vs Aripiprazole Comparative Trial (FACT)","status":"TERMINATED","sponsor":"Northwell Health","startDate":"2014-07","conditions":"Attenuated Psychosis Syndrome","enrollment":9},{"nctId":"NCT02624128","phase":"PHASE2","title":"Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck","status":"UNKNOWN","sponsor":"National Cancer Institute, Naples","startDate":"2015-02-23","conditions":"Squamous Cell Carcinoma of the Head and Neck","enrollment":39},{"nctId":"NCT02523859","phase":"PHASE3","title":"Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery","status":"TERMINATED","sponsor":"Paion UK Ltd.","startDate":"2015-07","conditions":"Anesthesia","enrollment":25},{"nctId":"NCT04050514","phase":"NA","title":"Side Effects of Mandibular Advancement Devices","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"2019-12-01","conditions":"Obstructive Sleep Apnea Syndrome, Temporomandibular Disorders","enrollment":65},{"nctId":"NCT02744391","phase":"PHASE4","title":"A Study of L-DOPA for Depression and Slowing in Older Adults","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2016-08-24","conditions":"Major Depressive Disorder, Dysthymia, Depression Not Otherwise Specified","enrollment":47},{"nctId":"NCT04777045","phase":"PHASE3","title":"Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2019-10-25","conditions":"Microvascular Angina, Coronary Vasospasm, Microvascular Ischemia of Myocardium","enrollment":85},{"nctId":"NCT05031676","phase":"NA","title":"Opioid Free Anesthesia in Maxillofacial Surgery","status":"COMPLETED","sponsor":"Université NAZI BONI","startDate":"2019-02-15","conditions":"Maxillofacial Surgery","enrollment":66},{"nctId":"NCT04426578","phase":"PHASE2","title":"Role of Perhexiline in Hypertrophic Cardiomyopathy","status":"UNKNOWN","sponsor":"Flinders University","startDate":"2020-12-01","conditions":"Hypertrophic Cardiomyopathy","enrollment":60},{"nctId":"NCT02179788","phase":"PHASE1, PHASE2","title":"Metformin to Augment Low Milk Supply (MALMS) Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-06","conditions":"Low Milk Supply, Pre-diabetes, Insulin Resistance","enrollment":15},{"nctId":"NCT02871349","phase":"EARLY_PHASE1","title":"Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2016-08","conditions":"Autism Spectrum Disorder","enrollment":69},{"nctId":"NCT03808935","phase":"PHASE3","title":"Cannabis Extract in Refractory Epilepsy Study","status":"TERMINATED","sponsor":"The Epilepsy Research Program of the Ontario Brain Institute","startDate":"2019-01-10","conditions":"Drug Resistant Epilepsy","enrollment":17},{"nctId":"NCT02642393","phase":"PHASE3","title":"Study of Urate Elevation in Parkinson's Disease, Phase 3","status":"COMPLETED","sponsor":"Michael Alan Schwarzschild","startDate":"2016-06","conditions":"Parkinson's Disease","enrollment":298},{"nctId":"NCT04447859","phase":"PHASE3","title":"16-week Flexible vs. 8-week Semaglutide Titration","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-02-23","conditions":"Diabetes type2","enrollment":100},{"nctId":"NCT04410211","phase":"NA","title":"Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2018-06-01","conditions":"Gastro Esophageal Reflux, Gastric Ulcer, Sedation Complication","enrollment":30},{"nctId":"NCT01774227","phase":"NA","title":"the Pops-titration Versus the Slow-coagulation Cyclophotocoagulation in Treatment of Refractory Glaucoma","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2013-05","conditions":"Glaucoma, Intraocular Pressure","enrollment":98},{"nctId":"NCT02999126","phase":"PHASE4","title":"Slow Stepwise Propofol TCI Induction for Titration Anesthesia Maintenance","status":"UNKNOWN","sponsor":"Hospital Italiano de Buenos Aires","startDate":"2016-08","conditions":"Target Controlled Infusion, Induction of Anesthesia, Bispectral Index","enrollment":60},{"nctId":"NCT00622739","phase":"PHASE4","title":"Ziprasidone in Pediatric Bipolar Disorder","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2007-02","conditions":"Bipolar Disorder","enrollment":28},{"nctId":"NCT00880997","phase":"PHASE1","title":"The Efficacy of Doxazosin for Cocaine Users","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2009-09","conditions":"Cocaine Dependence","enrollment":35},{"nctId":"NCT02566278","phase":"NA","title":"Determination of Upper Airway Collapsibility During Routine CPAP Titration","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2015-10-20","conditions":"Obstructive Sleep Apnea","enrollment":20},{"nctId":"NCT02181231","phase":"PHASE1, PHASE2","title":"Buprenorphine Used With Treatment Resistant Depression in Older Adults","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-06-01","conditions":"Major Depressive Disorder, Depression","enrollment":18},{"nctId":"NCT02841241","phase":"PHASE2","title":"Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia","status":"COMPLETED","sponsor":"Intermountain Health Care, Inc.","startDate":"2016-04","conditions":"Septic Shock","enrollment":7},{"nctId":"NCT03701880","phase":"NA","title":"Early Use of Ivabradine in Heart Failure","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2018-09-16","conditions":"Heart Failure With Reduced Ejection Fraction, Decompensated Heart Failure","enrollment":50},{"nctId":"NCT02263248","phase":"PHASE1, PHASE2","title":"Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2014-12","conditions":"Major Depressive Disorder, Depression","enrollment":56},{"nctId":"NCT03173781","phase":"NA","title":"Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease","status":"COMPLETED","sponsor":"Colorado Springs Neurological Associates","startDate":"2016-04","conditions":"Parkinson's Disease","enrollment":21},{"nctId":"NCT00156715","phase":"PHASE4","title":"Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2004-03","conditions":"Schizophrenia, Schizoaffective Disorder, Psychotic Disorder","enrollment":23},{"nctId":"NCT02635100","phase":"NA","title":"Multinight CPAP for Sleep Apnea Patients","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2015-05","conditions":"Sleep Apnea, Sleep Disordered Breathing","enrollment":1},{"nctId":"NCT01119677","phase":"PHASE1","title":"A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers","status":"COMPLETED","sponsor":"Biogen","startDate":"2010-05-05","conditions":"Healthy Volunteers","enrollment":120},{"nctId":"NCT01054599","phase":"NA","title":"Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?","status":"COMPLETED","sponsor":"American Academy of Neurology","startDate":"2009-01","conditions":"Epilepsy","enrollment":29},{"nctId":"NCT03140982","phase":"NA","title":"Is Anesthetic Loss of Consciousness a Top Down or Bottom up Phenomenon. What Does the Neurologic Examination Say?.","status":"COMPLETED","sponsor":"Universidad del Desarrollo","startDate":"2016-06-01","conditions":"Anesthesia; Functional","enrollment":16},{"nctId":"NCT02893995","phase":"PHASE4","title":"Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension","status":"WITHDRAWN","sponsor":"United Therapeutics","startDate":"2017-02","conditions":"Pulmonary Arterial Hypertension","enrollment":""},{"nctId":"NCT02428231","phase":"PHASE3","title":"Tecfidera Slow-Titration Study","status":"TERMINATED","sponsor":"Biogen","startDate":"2015-04","conditions":"Multiple Sclerosis","enrollment":62},{"nctId":"NCT02224664","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease","status":"COMPLETED","sponsor":"Pfizer","startDate":"2014-10","conditions":"Parkinson's Disease","enrollment":50},{"nctId":"NCT01811186","phase":"PHASE4","title":"An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)","status":"COMPLETED","sponsor":"Mundipharma Korea Ltd","startDate":"2012-12","conditions":"Chronic Pain","enrollment":261},{"nctId":"NCT01568112","phase":"PHASE3","title":"Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate","status":"COMPLETED","sponsor":"Biogen","startDate":"2012-04","conditions":"Healthy","enrollment":173},{"nctId":"NCT00282828","phase":"PHASE4","title":"Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2006-03","conditions":"Social Phobia","enrollment":397},{"nctId":"NCT00382291","phase":"PHASE4","title":"Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"University of Florida","startDate":"2009-02","conditions":"Obsessive-Compulsive Disorder","enrollment":56},{"nctId":"NCT00956189","phase":"NA","title":"Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2009-11","conditions":"Metabolic Syndrome X","enrollment":132},{"nctId":"NCT00406354","phase":"PHASE4","title":"Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-11","conditions":"Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder","enrollment":181},{"nctId":"NCT00646477","phase":"PHASE3","title":"ISIS 1 Therapeutic Effectiveness","status":"UNKNOWN","sponsor":"Tyco Healthcare Group","startDate":"2007-10","conditions":"OSAS (Obstructive Sleep Apneas Syndrome)","enrollment":24},{"nctId":"NCT00000172","phase":"PHASE3","title":"Evaluation of Galantamine in the Treatment of Alzheimer's Disease","status":"COMPLETED","sponsor":"Janssen, LP","startDate":"","conditions":"Alzheimer Disease","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":222,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Slow Titration","genericName":"Slow Titration","companyName":"University of Florida","companyId":"university-of-florida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Slow Titration is a medication that helps to gradually increase the dose of a drug to minimize side effects. Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}